<div>Our daughter, Evelyn, was born in December 2015.  All was normal for her first 3 years until she started preschool. At that point, we began to notice that she was struggling a bit with her speech and had issues with balance and clumsiness.  She was seen by a speech therapist and, at a later stage, was diagnosed with Dyspraxia (DCD).  Shortly after she turned 5 years old, we noticed that she was having issues with her sight.  We initially thought it related to a Sensory Processing Disorder, but then realised that it was more than that, and she seemed to have issues with her peripheral vision.  She didn't always know who was in the room with her, and she had to be guided up and down kerbs when we walked routes that she wasn't familiar with.  She was constantly falling over things in the playground and covered in awful bruises.  She was referred to Opthalmology in Temple Street Children's Hospital, and on Monday, July 12th 2021, we were given the news that our daughter was already legally blind and would lose the rest of her vision in time.
</div>
<div><br />
</div>
<div>It was a huge shock!  We cried many tears.  And while we did this, our little girl did what she had already been doing for months - she adapted and got on with it.  By the time she turned 6 years old in December 2021, Evelyn had lost the remainder of her sight and was completely blind.  She was given a bright pink cane to help her navigate her new world, and within 10 minutes of having it, it was as though it was already an extension of her arm.  As a family, we adapted, and we watched our little girl take on her new challenge with gusto.  With a view to the future possibility of gene therapy, we sent off a gene test for Evelyn and awaited the results.
</div>
<div><br />
</div>
<div>Unfortunately, in early May, on a normal Monday evening, just before bedtime, Evelyn had a seizure.  It started as an absence seizure, and by the time we spoke to Ambulance Services, it had developed into a tonic-clonic seizure.  Afterwards, she lay on our bed like a rag doll.  We looked at our little girl, lethargic and barely responding, and wondered what was happening to her.
</div>
<div><br />
</div>
<div>She was brought into Temple Street by ambulance and spent 4 nights there.  Many teams did many tests on her in those 4 days, and the genetic test results we had done earlier in the year were sought out.  On Friday, May 13th 2022, we were given the news that no parents can ever imagine.  The reason for Evelyn's delays, the reason for her sudden blindness, and her developed epilepsy was due to an inherited genetic disorder caused by the gene CLN3. The disease it causes is known as Juvenile Batten Disease.
</div>
<div><br />
</div>
<div>Evelyn is 6 years old.  She has been given a life sentence.  She will continue to decline.  She will lose her mobility.  She will eventually be unable to dress herself, feed herself, or even speak.  Our little girl who loves Disney Princesses, who knows all of the dialogue and songs of so many Disney movies and shows, will no longer be able to dance or sing along.  She'll be lucky if she lives to see her 20th birthday.
</div>
<div><br />
</div>
<div>As a family, we are devastated.  Even after months of processing this news, it is impossible to believe it is happening to our little girl.  The only thing we know how to do is get through each day, to concentrate on giving her and her sister and brother, happy memories, to live as normal a life as we can, for as long as we can.
</div>
<div><br />
</div>
<div>We are desperate to grab onto any bit of hope we can.  And in this age of medical advancements, there is hope.  There is a trial for a drug called Miglustat that is currently running for 5 patients over the age of 17, with CLN3 Batten Disease in the States.  They want to bring the next phase of the trial across the world, including children from 4 years old to 16 years old.  As far as we know, Evelyn is the only child in the Republic of Ireland with CLN3 Batten Disease, so the trial is unlikely to come here.  If we want her to take part, we will need to travel.
</div>
<div><br />
</div>
<div>And so we need help to raise funds to allow us to get her there and to travel back and forth for the 2 years that the trial will take.  Our family would appreciate if you could help in any way you can to get her there and give her a chance to fight this awful, debilitating disease.
</div>
<div><br />
</div>
<div>Thanks so much,
</div>
<div><br />
</div>
<div>Eddie, Jolene, Grace, Evelyn &amp; Benjamin
</div>

Paul Carmody

Brian & Deirdre

Anonymous

Jeanette Sheerin

Catherine Rosnsy

Katie Maguire

Anthony Walsh

Jackie Cullen

Robins Nest Sports Day Fundraiser

b sweetman

John Hardiman

Kevin Gaffney

Aidan O callaghan

Elaine Walsh

Eamon Price

Sarah Mulhall

Laura Medbury

Amy Kennedy

Eamon Devoy

Help Evelyn's Battle with Batten Disease (CLN3)

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

currencyCode

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

writePath

Stream Notification

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

Users Receiving Braze KYC Validation Failed

Native 11.3.0 and above

Influencer - Prod

US fundraisers and US users

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

isCampaignOwner

fundHasInstagramDeepLink

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

userCurrencyCode

Localized Currency

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

Help Evelyn's Battle with Batten Disease (CLN3)

Still €34,064 to go. Help us build momentum.